XML 12 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED BALANCE SHEETS (UNAUDITED) - JPY (¥)
¥ in Millions
Sep. 30, 2018
Mar. 31, 2018
Cash and cash deposits:    
Cash and cash equivalents ¥ 2,975,414 ¥ 2,354,639
Time deposits 194,827 315,445
Deposits with stock exchanges and other segregated cash 294,180 288,962
Total cash and cash deposits 3,464,421 2,959,046
Loans and receivables:    
Loans receivable (including \554,137 million and \601,864 million measured at fair value by applying the fair value option as of March 31, 2018 and September 30, 2018, respectively) 2,308,099 2,462,503
Receivables from customers (including \13 million and \8,634 million measured at fair value by applying the fair value option as of March 31, 2018 and September 30, 2018, respectively) 600,758 442,343
Receivables from other than customers 677,956 973,867
Allowance for doubtful accounts (3,964) (3,514)
Total loans and receivables 3,582,849 3,875,199
Collateralized agreements:    
Securities purchased under agreements to resell (including \1,186,096 million and \800,535 million measured at fair value by applying the fair value option as of March 31, 2018 and September 30, 2018, respectively) 15,412,852 9,853,898
Securities borrowed 4,509,602 6,383,845
Total collateralized agreements 19,922,454 16,237,743
Trading assets and private equity investments:    
Trading assets (including securities pledged as collateral of \5,486,551 million and \5,350,002 million as of March 31, 2018 and September 30, 2018, respectively; including \7,047 million and \7,984 million measured at fair value by applying the fair value option as of March 31, 2018 and September 30, 2018, respectively) 16,084,405 14,962,690
Private equity investments (including \4,416 million and \4,772 million measured at fair value by applying the fair value option as of March 31, 2018 and September 30, 2018, respectively) 18,055 17,466
Total trading assets and private equity investments 16,102,460 14,980,156
Other assets:    
Office buildings, land, equipment and facilities (net of accumulated depreciation and amortization of \397,834 million and \423,552 million as of March 31, 2018 and September 30, 2018, respectively) 323,938 338,984
Non-trading debt securities 451,875 485,891
Investments in equity securities 150,820 150,760
Investments in and advances to affiliated companies 418,330 408,034
Other (including \176,029 million and \179,039 million measured at fair value by applying the fair value option as of March 31, 2018 and September 30, 2018, respectively) 943,192 908,134
Total other assets 2,288,155 2,291,803
Total assets 45,360,339 40,343,947
LIABILITIES AND EQUITY    
Short-term borrowings (including \372,188 million and \408,344 million measured at fair value by applying the fair value option as of March 31, 2018 and September 30, 2018, respectively) 980,269 743,497
Payables and deposits:    
Payables to customers 1,318,876 1,176,773
Payables to other than customers 1,422,757 1,239,540
Deposits received at banks 1,182,640 1,151,342
Total payables and deposits 3,924,273 3,567,655
Collateralized financing:    
Securities sold under agreements to repurchase (including \435,905 million and \218,154 million measured at fair value by applying the fair value option as of March 31, 2018 and September 30, 2018, respectively) 18,645,764 14,759,010
Securities loaned (including \133,375 million and \136,454 million measured at fair value by applying the fair value option as of March 31, 2018 and September 30, 2018, respectively) 1,371,260 1,524,363
Other secured borrowings 420,362 413,621
Total collateralized financing 20,437,386 16,696,994
Trading liabilities 8,600,314 8,202,936
Other liabilities (including \25,482 million and \18,788 million measured at fair value by applying the fair value option as of March 31, 2018 and September 30, 2018, respectively) 877,846 950,534
Long-term borrowings (including \2,857,835 million and \3,140,801 million measured at fair value by applying the fair value option as of March 31, 2018 and September 30, 2018, respectively) 7,694,241 7,382,507
Total liabilities 42,514,329 37,544,123
Common stock    
No par value shares; Authorized-6,000,000,000 shares as of March 31, 2018 and September 30, 2018, Issued-3,643,562,601 shares as of March 31, 2018 and September 30, 2018, Outstanding-3,392,937,486 shares as of March 31, 2018 and 3,382,481,612 shares as of September 30, 2018 594,493 594,493
Additional paid-in capital 681,058 675,280
Retained earnings 1,681,445 1,696,890
Accumulated other comprehensive income 6,373 (59,356)
Total NHI shareholder's equity before treasury stock 2,963,369 2,907,307
Common stock held in treasury, at cost-250,625,115 shares as of March 31, 2018 and 261,080,989 shares as of September 30, 2018 (162,592) (157,987)
Total NHI shareholders' equity 2,800,777 2,749,320
Noncontrolling interests 45,233 50,504
Total equity 2,846,010 2,799,824
Total liabilities and equity 45,360,339 40,343,947
Variable Interest Entity, primary beneficiary [Member]    
Cash and cash deposits:    
Cash and cash equivalents 18,000 23,000
Total cash and cash deposits 18,000 23,000
Trading assets and private equity investments:    
Private equity investments (including \4,416 million and \4,772 million measured at fair value by applying the fair value option as of March 31, 2018 and September 30, 2018, respectively) 1,000 2,000
Total trading assets and private equity investments 1,259,000 1,186,000
Other assets:    
Office buildings, land, equipment and facilities (net of accumulated depreciation and amortization of \397,834 million and \423,552 million as of March 31, 2018 and September 30, 2018, respectively) 15,000 25,000
Other (including \176,029 million and \179,039 million measured at fair value by applying the fair value option as of March 31, 2018 and September 30, 2018, respectively) 62,000 66,000
Total other assets 77,000 91,000
Total assets 1,354,000 1,300,000
LIABILITIES AND EQUITY    
Short-term borrowings (including \372,188 million and \408,344 million measured at fair value by applying the fair value option as of March 31, 2018 and September 30, 2018, respectively) 149,000 124,000
Collateralized financing:    
Trading liabilities 21,000 22,000
Other liabilities (including \25,482 million and \18,788 million measured at fair value by applying the fair value option as of March 31, 2018 and September 30, 2018, respectively) 2,000 2,000
Long-term borrowings (including \2,857,835 million and \3,140,801 million measured at fair value by applying the fair value option as of March 31, 2018 and September 30, 2018, respectively) 804,000 829,000
Borrowings 953,000 953,000
Total liabilities ¥ 976,000 ¥ 977,000